Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.

By A. Heidenreich, Z. Varga, R. von Knobloch. Journal of Urology, 2002

640 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/4faa3a0a2b5eeb9b83e76a83c43b722fd91f63c9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. A. Heidenreich
2. Michel Bolla
3. N. Mottet
4. J. Bellmunt
5. V. Matveev
6. Steven Joniau
7. F. Zattoni
8. Thomas Wiegel

In Pulmonary and Respiratory Medicine

1. A. Heidenreich
2. Michel Bolla
3. N. Mottet
4. J. Bellmunt
5. V. Matveev
6. Steven Joniau
7. F. Zattoni
8. Thomas Wiegel

Citations in the corpus

• Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. (2012, background): “1% to 26% in contemporary patients [2–10].”
• Guidelines on Prostate Cancer (2013, background): “Studies have shown that 18F-fluoride PET/CT is a highly sensitive and specific imaging modality for detection of bone metastases (67, 68).”
• EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. (2011, background): “The decision to proceed with further diagnostic or staging workup is guided by which treatment options are available to the patient, taking the patient’s preference, age, and comorbidity into consideration [34–41].”